Compare Humana Inc (HUM) vs ThredUp Inc (TDUP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs ThredUp Inc — how do they compare? Humana Inc trades at $384.62 (market cap $44.77B), while ThredUp Inc trades at $3.06 (market cap $415.01M). The key difference: Humana Inc is far larger — about 107.9× ThredUp Inc's market cap, and Humana Inc pays a 0.95% dividend while ThredUp Inc pays none. Which is the better fit depends on your goals.
| HUM | TDUP | |
|---|---|---|
Market Cap | $44.77B | $415.01M |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $12.08 |
52-Week Low | $163.67 | $3.11 |
Enterprise Value | $52.12B | $413.19M |
Dividend Yield | 0.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $386.11, up 0.17% today, with a neutral technical outlook and mixed fundamentals. The stock shows strong revenue growth reaching $129.66B in 2025 but faces margin compression with net income margin declining to 0.88%. Recent Q2 2026 earnings beat expectations with EPS of $7.61 versus $7.27 expected, while management focuses on Medicare Advantage margin expansion and cost reductions.
Outlook remains cautiously optimistic with a consensus price target of $409.93 offering 6% upside potential. Key opportunities include Medicare Advantage growth and operational efficiency gains, while risks involve margin pressure, regulatory changes in healthcare, and competitive threats. Analyst sentiment leans neutral with 57% hold ratings amid ongoing business transformation.
ThredUp (TDUP) trades at $3.095, down 4.18% on the day, reflecting negative market reaction to recent earnings. The stock is technically bearish with key indicators showing mixed signals. Fundamentally, the company reported Q2 2026 revenue growth of 17% to $90.8 million but missed EPS expectations and cut its full-year revenue outlook, highlighting ongoing profitability challenges.
The outlook is cautious. While analyst consensus is a 'Buy' (57% of ratings), recent news indicates significant promotional headwinds and shareholder investigations. The primary opportunity lies in the company's strong gross margin and active buyer growth, but risks include persistent net losses and execution uncertainty. The stock's trajectory hinges on achieving profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About ThredUp Inc
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →
